Cargando…

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

The spike aspartic acid–614 to glycine (D614G) substitution is prevalent in global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains, but its effects on viral pathogenesis and transmissibility remain unclear. We engineered a SARS-CoV-2 variant containing this substitution. The var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yixuan J., Chiba, Shiho, Halfmann, Peter, Ehre, Camille, Kuroda, Makoto, Dinnon, Kenneth H., Leist, Sarah R., Schäfer, Alexandra, Nakajima, Noriko, Takahashi, Kenta, Lee, Rhianna E., Mascenik, Teresa M., Graham, Rachel, Edwards, Caitlin E., Tse, Longping V., Okuda, Kenichi, Markmann, Alena J., Bartelt, Luther, de Silva, Aravinda, Margolis, David M., Boucher, Richard C., Randell, Scott H., Suzuki, Tadaki, Gralinski, Lisa E., Kawaoka, Yoshihiro, Baric, Ralph S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775736/ https://www.ncbi.nlm.nih.gov/pubmed/33184236 http://dx.doi.org/10.1126/science.abe8499

Ejemplares similares

SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo
por: Hou, Yixuan J., et al.
Publicado: (2020)

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
por: Hou, Yixuan J., et al.
Publicado: (2020)

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
por: Leist, Sarah R., et al.
Publicado: (2020)

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels
por: Markmann, Alena J., et al.
Publicado: (2023)

Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors
por: Becker, Jonas, et al.
Publicado: (2022)

614. Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2021)

Host range, transmissibility and antigenicity of a pangolin coronavirus
por: Hou, Yixuan J., et al.
Publicado: (2023)

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
por: Premkumar, Lakshmanane, et al.
Publicado: (2020)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022)

In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
por: Kiso, Maki, et al.
Publicado: (2023)

Molecular pathology of emerging coronavirus infections
por: Gralinski, Lisa E, et al.
Publicado: (2015)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
por: Menachery, Vineet D., et al.
Publicado: (2020)

Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2017)

In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
por: Bauer, Lisa, et al.
Publicado: (2022)

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
por: Gralinski, Lisa E., et al.
Publicado: (2018)

Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
por: Bartelt, Luther A., et al.
Publicado: (2022)

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage
por: Huang, Sheng-Yu, et al.
Publicado: (2021)

Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
por: Edwards, Caitlin E., et al.
Publicado: (2020)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
por: Berical, Andrew, et al.
Publicado: (2019)

New Metrics for Evaluating Viral Respiratory Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2015)

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
por: Root, Heather B., et al.
Publicado: (2022)

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
por: Ozono, Seiya, et al.
Publicado: (2021)

The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters
por: Stauft, Charles B., et al.
Publicado: (2021)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
por: Halfmann, Peter J., et al.
Publicado: (2021)

Mucins and CFTR: Their Close Relationship
por: Okuda, Kenichi, et al.
Publicado: (2022)

P115 Pathogenic Influenza A viruses and SARS-Coronaviruses modulate global interferon stimulated gene induction through diverse mechanisms
por: Menachery, V.D., et al.
Publicado: (2012)

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
por: Valenzuela Nieto, Guillermo, et al.
Publicado: (2021)

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
por: Gallichotte, Emily N., et al.
Publicado: (2017)

496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection
por: Hawkins, P., et al.
Publicado: (2021)

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
por: Dinnon, Kenneth H., et al.
Publicado: (2020)

Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Erratum for Markmann et al., “Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals”
por: Markmann, Alena J., et al.
Publicado: (2021)

Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
por: Markmann, Alena J., et al.
Publicado: (2021)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

Generation of Mature DENVs via Genetic Modification and Directed Evolution
por: Tse, Longping V., et al.
Publicado: (2022)

HER2-mediated enhancement of Ebola virus entry
por: Kuroda, Makoto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sqgv9b7t2rm9ek9b4b71did01o